Cargando…
Engineered Plant-Derived Nanovesicles Facilitate Tumor Therapy: Natural Bioactivity Plus Drug Controlled Release Platform
Tumors are the second-most common disease in the world, killing people at an alarming rate. As issues with drug resistance, lack of targeting, and severe side effects are revealed, there is a growing demand for precision-targeted drug delivery systems. Plant-derived nanovesicles (PDNVs), which areco...
Autores principales: | Chen, Xiaohang, Ji, Shuaiqi, Yan, Yuxiang, Lin, Shuoqi, He, Lianghang, Huang, Xiaoyu, Chang, Lin, Zheng, Dali, Lu, Youguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460188/ https://www.ncbi.nlm.nih.gov/pubmed/37635909 http://dx.doi.org/10.2147/IJN.S413831 |
Ejemplares similares
-
Plant-derived nanovesicles: harnessing nature's power for tissue protection and repair
por: Chen, Xiaohang, et al.
Publicado: (2023) -
Engineering Cell-Derived Nanovesicles for Targeted Immunomodulation
por: Sayyed, Adil Ali, et al.
Publicado: (2023) -
Bioinspired engineering of fusogen and targeting moiety equipped nanovesicles
por: Wang, Lixue, et al.
Publicado: (2023) -
Genetically Engineered‐Cell‐Membrane Nanovesicles for Cancer Immunotherapy
por: Cheng, Qinzhen, et al.
Publicado: (2023) -
Bio-Inspired Synthetic Nanovesicles for Glucose-Responsive
Release of Insulin
por: Tai, Wanyi, et al.
Publicado: (2014)